跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 190 条关于
“YAP101”
全部
190
临床试验
140
药物
35
机构
0
资讯
15
10个月前
Medley Therapeutics Advances First-in-Human Gene Therapy Trial for Heart Regeneration After Safety Milestone
去年
Calluna Pharma's CAL101 Demonstrates Favorable Safety Profile in Phase I Trial for Fibrotic Diseases
去年
Calluna Pharma Appoints Mark Gaffney as CEO, Advances CAL101 Program
去年
Triumvira Immunologics Presents Promising Phase 1 Data for TAC101-CLDN18.2 in Solid Tumors
去年
Novartis' OAV101 IT Gene Therapy Shows Motor Function Improvement in Older SMA Patients
去年
Calluna Pharma's CAL101 Demonstrates Favorable Safety Profile in Phase 1 Trial for Fibrotic Diseases
6个月前
Kupando Raises €10 Million to Advance Dual TLR Agonist KUP101 into Phase 1b Clinical Trial
5个月前
Calluna Pharma Completes Enrollment in Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis
去年
Alebund's AP301 Meets Primary Endpoint in Phase 3 Trial for Hyperphosphatemia in Dialysis Patients
去年
Kaida BioPharma Partners with Northway Biotech to Advance Novel Prolactin Receptor Antagonist KAD101 for Platinum-Resistant Ovarian Cancer
第 1 页,共 2 页
上一页
下一页